Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.32, indicating limited leverage. However, the company's liquidity position is assessed as medium, with a current ratio of 1.01, suggesting a marginal ability to meet short-term obligations. Free cash flow is negative at -54.57 million INR, primarily due to capital expenditures of -182.47 million INR, which may signal ongoing investment in infrastructure or equipment. Profitability metrics are strong relative to the healthcare services industry. The company reports a return on equity (ROE) of 36.29% and a return on assets (ROA) of 17.01%, both exceeding typical industry medians for asset-light healthcare providers. Gross profit of 355.98 million INR on revenue of 402.42 million INR reflects a gross margin of 88.46%, indicating efficient cost management in service delivery. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic diversification beyond India. This lack of segment or geographic diversification increases exposure to local economic and regulatory shifts. Outlook for the current fiscal year shows a projected revenue growth of 12.3% year-over-year, driven by expansion in outpatient services and new facility openings. The next fiscal year is expected to see a slower growth rate of 5.8%, as the company shifts focus to optimizing existing infrastructure. Risk factors include a medium liquidity risk due to negative net cash after subtracting total debt, and a low dilution potential based on unchanged basic and diluted shares outstanding. No recent equity issuance or ATM programs have been disclosed, reducing near-term dilution pressure. Recent filings and transcripts highlight the company's focus on expanding its dialysis services and improving patient access in rural Gujarat. No material regulatory or litigation risks were disclosed in the latest 10-K equivalent filing.